Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Camil Alimentos
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Capacity Expansion And International Markets Will Unlock Potential
Key Takeaways Strategic focus on value-added and premium products, combined with operational efficiency and brand investments, is expected to boost margins and consumer loyalty. International expansion and increased capacity utilization reduce reliance on Brazil, supporting growth while aligning with evolving consumer preferences for healthier options.
View narrative
R$7.43
FV
38.3% undervalued
intrinsic discount
5.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
1508
China Reinsurance (Group)
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Digital Transformation And EV Insurance Will Open New Markets
Key Takeaways Innovative products in climate change and EV insurance could enhance revenue by addressing unmet demand and emerging risks. Focus on digital transformation and global expansion may improve operational efficiency and boost revenue growth in strategic regions.
View narrative
HK$1.21
FV
17.6% overvalued
intrinsic discount
5.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
Dexterra Group
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
US Facility Management And Mobile Camps Will Unlock New Horizons
Key Takeaways Strategic acquisitions and service integration are expanding market reach, recurring revenue, and margin accretion across North America. Operational efficiency and a robust contract pipeline enhance earnings resiliency and support long-term revenue and cash flow stability.
View narrative
CA$12.79
FV
22.7% undervalued
intrinsic discount
7.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
28
users have followed this narrative
Updated
narrative
5N Plus
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
North American Supply Chain Will Secure A Clean Energy Future
Key Takeaways Strengthened supply agreements, capacity expansions, and backlogs in key markets drive long-term revenue growth, earnings stability, and reduce risk from customer concentration. Strategic investments in next-gen materials and supply chain integrity enhance margins, pricing power, and market share amid increasing global focus on clean energy and ESG.
View narrative
CA$18.45
FV
17.0% undervalued
intrinsic discount
15.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Haemonetics
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Shift To High-Margin Interventional Technologies Will Strengthen Future Prospects
Key Takeaways Strategic divestitures and focus on high-margin segments expected to enhance profitability and drive revenue and margin growth. New agreements and innovations in Blood Management Technologies position Haemonetics for significant market share increases and global technology adoption.
View narrative
US$85.18
FV
36.6% undervalued
intrinsic discount
2.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Oscar Health
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
ACA Uncertainties And Digital Efficiencies Will Shape Future Outcomes
Key Takeaways Higher claims costs and evolving policy risks threaten profitability and future membership growth, despite efforts to reprice plans and leverage digital adoption trends. Regulatory shifts and industry consolidation could inflate expenses and hinder Oscar's ability to realize anticipated technology-driven cost advantages and margin improvements.
View narrative
US$11.29
FV
37.0% overvalued
intrinsic discount
5.37%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
1
users have commented on this narrative
85
users have followed this narrative
4 days ago
author updated this narrative
Tapestry
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Brand Investments Will Fortify Customer Engagement In Europe And Greater China
Key Takeaways Targeting Gen Z and millennials, alongside strategic brand investments, aims to boost long-term growth and customer retention through elevated revenues. Cost efficiencies and product line expansion intend to enhance gross margins and market share, supporting diversified growth across Tapestry's brand portfolio.
View narrative
US$106.39
FV
2.5% overvalued
intrinsic discount
2.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
Updated
narrative
Banco Santander-Chile
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Chilean Banking Will Stumble Amid Sustained Loan Headwinds
Key Takeaways Loan growth remains sluggish amid weak corporate demand, regulatory caps, and demographic challenges, limiting future revenue and client base expansion. Elevated credit risk and compressed net interest margins may weigh on asset quality and earnings, with non-interest income growth further restricted by regulation.
View narrative
CL$60.16
FV
3.4% undervalued
intrinsic discount
11.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
Main Street Capital
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Shifting Focus And Rising Credit Issues Signal Turbulence Ahead For Growth
Key Takeaways Shifting focus to new lower middle market platforms may risk the quality and performance of investments, potentially affecting future income and asset value. Strategic changes, including portfolio adjustments and internal resource re-allocation, could lead to income fluctuation and operational efficiency challenges.
View narrative
US$56.25
FV
16.7% overvalued
intrinsic discount
1.23%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
33
users have followed this narrative
13 days ago
author updated this narrative
Value any company in seconds
Popular companies